Serum lectin-like oxidized-low density lipoprotein receptor-l and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome
المؤلفون المشاركون
Sayyid, Ali Shaykh Md.
Zhao, Zhenyu
Guo, Lanyan
Li, Fei
Deng, Xu
Deng, Hai
Xia, Ke
Yang, Tianlun
المصدر
Iranian Red Crescent Medical Journal
العدد
المجلد 16، العدد 8 (31 أغسطس/آب 2014)، ص ص. 1-8، 8ص.
الناشر
تاريخ النشر
2014-08-31
دولة النشر
الإمارات العربية المتحدة
عدد الصفحات
8
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : Coronary artery disease (CAD) is a major public health problem for developed and developing countries and is the single leading cause of death worldwide.
Objectives : There is very few evidence regarding changes of both serum Lectin-like oxidized-low density lipoprotein receptor-i (LOX-i) and adiponectin in patients with (AD accompanied with metabolic syndrome (MS).
Here we aimed to evaluate serum levels of LOX-i and adiponectin in patients with CAD accompanied with MS.
Patients and methods : Thirty patients with coronary artery disease without metabolic syndrome, 30 patients with coronary artery disease and metabolic syndrome, 30 ones with metabolic syndrome and 30 healthy subjects were enrolled.
For all subjects, a questionnaire was filled to collect data, and peripheral blood samples were collected aseptically from the antecubital vein to measure serum Lectin-like oxidized-low density lipoprotein receptor-i and adiponectin levels by enzyme-linked immunosorbent assay.
Results : Serum LOX-i level was highest in CAD + MS group ; the difference between control and disease groups was statistically significant (P < 0.001).
Adiponectin level had the lowest value in CAD + MS group ; the difference between control and disease groups was statistically significant (P < 0.05).
No significant differences were observed in serum Lectin-like oxidized-low density lipoprotein receptor-iand adiponectin in patients with different ages and gender.
Serum LOX-i level was changed negatively and linearly (R2 = 0.721) correlated with adiponectin level in different groups.
Conclusions : Patient with CAD and MS had higher risk than those with only CAD because of lipid and glucose metabolism abnormalities.
Combination measurements of serum LOX-i and adiponectin levels may be helpful to evaluate the severity of CAD together with MS.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Sayyid, Ali Shaykh Md.& Zhao, Zhenyu& Guo, Lanyan& Li, Fei& Deng, Xu& Deng, Hai…[et al.]. 2014. Serum lectin-like oxidized-low density lipoprotein receptor-l and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome. Iranian Red Crescent Medical Journal،Vol. 16, no. 8, pp.1-8.
https://search.emarefa.net/detail/BIM-397497
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Sayyid, Ali Shaykh Md.…[et al.]. Serum lectin-like oxidized-low density lipoprotein receptor-l and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome. Iranian Red Crescent Medical Journal Vol. 16, no. 8 (Aug. 2014), pp.1-8.
https://search.emarefa.net/detail/BIM-397497
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Sayyid, Ali Shaykh Md.& Zhao, Zhenyu& Guo, Lanyan& Li, Fei& Deng, Xu& Deng, Hai…[et al.]. Serum lectin-like oxidized-low density lipoprotein receptor-l and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome. Iranian Red Crescent Medical Journal. 2014. Vol. 16, no. 8, pp.1-8.
https://search.emarefa.net/detail/BIM-397497
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 8
رقم السجل
BIM-397497
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر